The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose-escalation/expansion clinical trial of mocetinostat in combination with vinorelbine in adolescents and young adults with refractory and/or recurrent rhabdomyosarcoma: Interim results.
 
Noah Federman
Stock and Other Ownership Interests - Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Loxo; Zelda Therapeutics
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics
 
Jacquelyn Crane
No Relationships to Disclose
 
Amanda M Gonzales
No Relationships to Disclose
 
Rubi Arias
No Relationships to Disclose
 
Munther Baroudi
No Relationships to Disclose
 
Arun S. Singh
Stock and Other Ownership Interests - AntiCancer; Certis Oncology Solutions
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Lilly
Speakers' Bureau - Daiichi Sankyo; Deciphera; Eisai; Lilly; MJH Life Sciences; Novartis; Scripps Health
Research Funding - Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); deciphera (Inst); Lilly (Inst); Nanocarrier (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Lilly; Novartis
Other Relationship - Certis Oncology Solutions